Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

NCT06908928

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • City of Hope Duarte, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Anschutz Medical Center Aurora, Colorado, United States
  • UChicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

NCT03808337

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Natera, Inc. (Data and Specimen Analysis Only) San Carlos, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • WCHN Norwalk Hospital - Data Collection Norwalk, Connecticut, United States
  • Baptist Alliance - McI Miami, Florida, United States
View Trial Details
Recruiting

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

NCT04683679

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

NCT07281976

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

NCT06926920

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Los Angeles Cancer Network (LACN) - Good Sam Los Angeles, California, United States
  • Winship Cancer Institute - Emory University Atlanta, Georgia, United States
  • The University of Kansas Hospital Westwood, Kansas, United States
  • Siteman Cancer Center St Louis, Missouri, United States
View all 16 locations
View Trial Details

Related conditions